We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-1.75%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$742M
AUM Growth
+$71.9M
Cap. Flow
+$95.5M
Cap. Flow %
12.87%
Top 10 Hldgs %
60.42%
Holding
166
New
21
Increased
99
Reduced
7
Closed
7

Top Buys

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$23M
2
ETP
Energy Transfer Partners, L.P.
ETP
+$18.5M
3
WPZ
Williams Partners L.P.
WPZ
+$12.3M
4
BPL
Buckeye Partners, L.P.
BPL
+$9.48M
5
EPD icon
Enterprise Products Partners
EPD
+$8.44M

Top Sells

Rank Stock Value
1
OKS
Oneok Partners LP
OKS
+$34.2M
2
PAA icon
Plains All American Pipeline
PAA
+$1.69M
3
CEQP
Crestwood Equity Partners LP
CEQP
+$1.62M
4
MMP
Magellan Midstream Partners, L.P.
MMP
+$1.55M
5
FNCL icon
Fidelity MSCI Financials Index ETF
FNCL
+$1.4M

Sector Composition

Rank Sector Weight
1 Energy 73.54%
2 Healthcare 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JUNO
76
DELISTED
Juno Therapeutics, Inc.
JUNO
$640K 0.09%
14,261
+1,304
+10% +$44.5K
TLT icon
77
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$610K 0.08%
+4,889
New +$614K
KYNB
78
Kyntra Bio
KYNB
$28.5M
$607K 0.08%
451
+41
+10% +$43.2K
IMMU
79
DELISTED
Immunomedics Inc
IMMU
$598K 0.08%
42,784
+3,913
+10% +$39K
BPMC
80
DELISTED
Blueprint Medicines
BPMC
$592K 0.08%
8,495
+777
+10% +$41.5K
FOLD
81
DELISTED
Amicus Therapeutics
FOLD
$576K 0.08%
38,223
+3,496
+10% +$46.2K
RGNX icon
82
Regenxbio
RGNX
$623M
$569K 0.08%
17,271
+1,580
+10% +$35.6K
IMGN
83
DELISTED
Immunogen Inc
IMGN
$536K 0.07%
70,035
+6,406
+10% +$42.6K
ARRY
84
DELISTED
Array Biopharma Inc
ARRY
$520K 0.07%
42,236
+3,863
+10% +$35.9K
ONCE
85
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$519K 0.07%
5,818
+266
+5% +$20.2K
ALNY icon
86
Alnylam Pharmaceuticals
ALNY
$36.3B
$518K 0.07%
4,411
+404
+10% +$34.5K
MCRB icon
87
Seres Therapeutics
MCRB
$48M
$518K 0.07%
1,614
+148
+10% +$40.5K
EPZM
88
DELISTED
Epizyme, Inc
EPZM
$509K 0.07%
26,709
+2,443
+10% +$37.3K
SHLX
89
DELISTED
Shell Midstream Partners, L.P.
SHLX
$501K 0.07%
18,010
+3,334
+23% +$93.5K
PBYI icon
90
Puma Biotechnology
PBYI
$406M
$497K 0.07%
4,147
+380
+10% +$35.3K
ICPT
91
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$493K 0.07%
8,501
– –
ITCI
92
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$483K 0.07%
30,600
+2,799
+10% +$41.1K
PTLA
93
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$483K 0.07%
8,940
+818
+10% +$48K
MYOK
94
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$478K 0.06%
11,162
-10,245
-48% -$327K
RXDX
95
DELISTED
Ignyta, Inc.
RXDX
$474K 0.06%
38,356
+3,508
+10% +$36.2K
ESPR
96
DELISTED
Esperion Therapeutics
ESPR
$464K 0.06%
9,250
+846
+10% +$40.8K
AKBA icon
97
Akebia Therapeutics
AKBA
$327M
$453K 0.06%
23,019
+2,106
+10% +$32.4K
FPRX
98
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$449K 0.06%
10,966
+1,003
+10% +$31.5K
AVXS
99
DELISTED
AveXis, Inc. Common Stock
AVXS
$448K 0.06%
4,636
+424
+10% +$38.2K
AIMT
100
DELISTED
Aimmune Therapeutics
AIMT
$444K 0.06%
17,898
+1,637
+10% +$35.3K
2 3
4
5 6

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q3 2017 Portfolio in Review

As of Q3 2017, Virtus ETF Advisers held 166 positions worth $742M, up 11% from $670M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Virtus ETF Advisers deployed $95.5M of net new capital in Q3 2017, opening 21 new positions and adding to 99 existing holdings. Its largest new stake was Direxion Daily Financial Bull 3x ETF: 20,503 shares worth $1.15M.

By sector, the portfolio is most concentrated in Energy at 74% of assets, down from 74% a quarter earlier, followed by Healthcare.

On the sell side, the largest reduction was Plains All American Pipeline, an estimated $1.69M trimmed.

  • Virtus ETF Advisers's largest Q3 2017 buy was Direxion Daily Financial Bull 3x ETF: 20,503 shares worth $1.15M.
  • Virtus ETF Advisers added most to Marathon Petroleum in Q3 2017, an estimated $23M increase.
  • Virtus ETF Advisers's biggest Q3 2017 reduction was Plains All American Pipeline, cutting an estimated $1.69M.
  • Virtus ETF Advisers fully exited Oneok Partners LP in Q3 2017, selling an estimated $34.2M.
  • Virtus ETF Advisers's ten largest holdings make up 60% of its $742M portfolio in Q3 2017.
  • Virtus ETF Advisers opened 21 new positions and closed 7 in Q3 2017.
  • Virtus ETF Advisers's portfolio value rose 11% quarter-over-quarter to $742M.

Based on Virtus ETF Advisers's 13F filing for Q3 2017, filed 14 Nov 2017.